3M, Verily, to unveil performance matrix at HIMSS18

Demonstrations will show how the marriage of clinical and claims data in risk-adjusted algorithms can improve quality and reduce cost.

By Susan Morse

February 23, 2018

09:20 AM

Last year at HIMSS17, 3M Health Information Systems and Verily announced their expanded partnership in building a performance matrix.

This year at HIMSS18, 3M and Verily will unveil the results of the performance matrix that identifies clinical opportunities for population health improvement, in real time, based on provider and payer data.

It’s the culmination of a year-and-a-half of building custom algorithms to risk adjust all of the clinical and claims data.

“Our official launch is at HIMSS,” said Jason Burke, vice president of Data Informatics, 3M Health Information Systems. “Today we have 15, 16 early adopter clients, mostly providers; we have three payers. We have a large list of active organizations that are interested. What we’ll be showing there are demonstrations that show organizations real data about their own organization. Providers will be able to see how they’re performing against their peers in an apples-to-apples way.”

Most analytic companies are looking at data from a single-slice view to determine the length of stay, readmissions, preventable complications and other information, he said. Algorithms built with Verily are able to look at how preventable complications impact length of stay.

“It’s not just one problem, it’s looking at a range of problems,” Burke said. “At the conference, we’ll be working with executives and show the output. We haven’t found a provider organization that hasn’t seen at least a 3-to-1 return. Most times, it’s 10-to-1, just based on the first few measures we built out. We have 31 new measures.”

The ability to synchronize claims and other information to have a common meaning across data sets is the result of a collaboration with Verily, the life sciences health data company that’s under the same Alphabet umbrella as Google.

Hospital CMOs can use the performance matrix to know the expected outcomes and cost, including any cost overruns, in real time, according to Jared Joselyn, global head of corporate development for Verily.

“You don’t want to understand six months later why you have a higher rate of sepsis,” Joselyn said. “It allows you to drill down on a more granular level. Ideally, it’s something for everybody. How they use it is up to them.”

3M Health Information Services will be at Booth 7601.